CG Stock Recent News

CGBD features an 11.5% yield and trades at a 16% discount to NAV. The recent merger with CSL III increased portfolio size, improved first-lien allocation, and eliminated preferred stock dilution overhang. Despite a slight NAV decline and rising non-accruals, portfolio quality remains solid and returns are in line with the sector average.

Investment firm Carlyle Group has partnered with U.S. banking giant Citigroup to provide asset-backed financing to fintech lenders, the companies said on Thursday.

Investors looking for stocks in the Financial - Investment Management sector might want to consider either Affiliated Managers Group (AMG) or Carlyle Group (CG). But which of these two companies is the best option for those looking for undervalued stocks?

Mark Jenkins, head of global credit at Carlyle joins CNBC from the sidelines of the SuperReturn conference to discuss the firm's expansion into Europe and how Trump's tariffs are impacting the private market.

Transaction positions company for accelerated growth through improved capital structure and simplified governance LINDON, Utah and NEW YORK , June 4, 2025 /PRNewswire/ -- Trucordia today announced it will receive a $1.3 billion strategic investment from global investment firm Carlyle's Global Credit platform. The transaction will reduce Trucordia's leverage and simplify its governance structure by repurchasing units from existing minority investors.

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2025) - Carlyle Commodities Corp. (CSE: CCC) (FSE: BJ4) (OTC: CCCFF) ("Carlyle" or the "Company") is pleased to announce, that further to its news release dated May 26, 2025, it has closed its previously announced transaction with Axcap Ventures Inc. ("Axcap") to sell a 100% interest in its Newton Gold Project (the "Newton Project"), located in British Columbia, Canada (the "Transaction"), pursuant to the terms of the Mineral Property Purchase Agreement dated May 23, 2025 (the "Agreement"). Under the terms of the Agreement, in consideration of the Newton Project, Carlyle received aggregate consideration comprising cash, shares and warrants, as follows: $500,000 in cash payments; 500,000 common share purchase warrants of Axcap (the "Payment Warrants"), exercisable at $0.20 per share until June 3, 2028; 3,750,000 common shares of Axcap (the "Initial Payment Shares"); and Common shares of Axcap valued at $1,250,000 (the "Secondary Pay

AlpInvest Partners has raised $4.1 billion for its ninth co-investment fund, an executive at the unit of private equity group Carlyle said, showing continued appetite among investors for access to buyout firms' dealmaking.

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio (NASDAQ: BLUE) (“bluebird”), a pioneer in gene therapies for severe genetic diseases, today announced the completion of its sale to funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP (“SK Capital”). With the closing of the transaction, bluebird's common stock has ceased trading and will no longer be publicly listed. Carlyle and SK Capital have provided significant primary capital to support and scale bluebir.

Carlyle Secured Lending's fundamentals remain solid, but rising non-accruals and shrinking net investment income raise concerns about portfolio health and dividend sustainability. Despite a 21% price drop and a 12.4% dividend yield, I maintain a hold rating due to ongoing NAV declines and limited earnings coverage for distributions. The portfolio's first lien, senior secured focus, and floating rate exposure are positives, but higher rates are pressuring borrowers and increasing credit risk.

WASHINGTON & NEW YORK--(BUSINESS WIRE)--Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and Beacon Parent Holdings, L.P. (“Parent”) today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) for either (x) $3.00 per share in cash and a contingent value right per share, entitling the holder to a payment of $6.84 in cash per contingent value right (“CVR”) if bluebird's c.